Related Experiment Video
Updated: Jan 21, 2026

Elastic Staining on Paraffin-embedded Slides of pT3N0M0 Gastric Cancer Tissue
Published on: May 1, 2019
GKN2 promotes oxidative stress-induced gastric cancer cell apoptosis via the Hsc70 pathway
Ziqiang Zhang1, Hongyuan Xue1, Yuanqiang Dong1
1Departments of General Surgery, Huashan Hospital, Fudan University, 12 Middle Urumqi Road, Shanghai, 200040, People's Republic of China.
Background:
The GKN2 is a secretory protein, whose levels decrease in gastric cancer. The present study aimed to investigate the expression, function and mechanism of action of GKN2 in gastric cancer.
Methods:
Molecular biology assays were performed to elucidate the function and underlying mechanisms of GKN2 in gastric cancer under stress-induced condition in vivo and in vitro. Clinical specimens were used to assess the correlation of GKN2 and prognosis.
Results:
We found that overexpression of GKN2 significantly enhanced apoptosis and growth arrest in vitro. GKN2 expression increased in gastric cancer cells exposed to hydrogen peroxide and promoted reactive oxygen species-induced mitochondrial dysfunction and resulted in increased cell apoptosis via inhibition of NF-κB signaling pathway and activation of JNK signaling pathway through the direct interaction of GKN2 with Hsc70. Trefoil factor 1 might contribute to the tumor suppressing effects of GKN2. MiR-216a downregulated GKN2 expression. GKN2 also inhibited xenograft tumor growth and was an independent and significant prognostic factor for patients with gastric cancer treated with oxaliplatin.
Conclusions:
Taken together, our data indicate that GKN2 may increase sensitivity of GC cells to the drugs which increase ROS levels in tumors. Inhibition of the interaction between GKN2 and Hsc70 could attenuate the effects induced by GKN2. GKN2 overexpression could be used to determine the subgroup of patients to obtain the more favorable outcome of oxaliplatin treatment and may be used as biomarker of the prognosis of this cancer.
Insights
Gastric cancer protein GKN2, when overexpressed, enhances apoptosis and inhibits tumor growth. GKN2 may serve as a prognostic biomarker for oxaliplatin treatment in gastric cancer patients.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- GKN2 is a secretory protein with decreased levels in gastric cancer.
- Its role in gastric cancer progression and treatment response requires further elucidation.
Purpose of the Study:
- To investigate the expression, function, and mechanism of GKN2 in gastric cancer.
- To assess GKN2's potential as a prognostic biomarker.
Main Methods:
- In vitro and in vivo molecular biology assays were employed.
- Clinical specimens were analyzed to correlate GKN2 expression with patient prognosis.
- Mechanisms involving signaling pathways (NF-κB, JNK) and protein interactions (GKN2-Hsc70) were studied.
Main Results:
- GKN2 overexpression induced apoptosis and growth arrest in gastric cancer cells.
- GKN2 modulated reactive oxygen species-induced mitochondrial dysfunction and inhibited NF-κB/activated JNK signaling.
- GKN2 inhibited xenograft tumor growth and was a significant prognostic factor for oxaliplatin-treated patients.
Conclusions:
- GKN2 enhances gastric cancer cell sensitivity to ROS-increasing drugs.
- GKN2's interaction with Hsc70 is crucial for its effects.
- GKN2 overexpression can identify patients likely to benefit from oxaliplatin therapy, serving as a prognostic biomarker.
Related Concept Videos
Nitric Oxide Signaling Pathway
Apoptosis
The Eukaryotic Promoter Region
Oxidation Numbers
Gastric Motility
Peristaltic Waves and Chyme Formation
Upon food entry, the stomach initiates...
C4 Pathway and CAM
C4 Pathway
The C4 pathway is used by plants such as...

